Wilson's disease: Molecular basis, clinical manifestations, and rational treatment

被引:0
|
作者
Beuers, U
Gasser, T
机构
[1] Univ Munich, Klinikum Grosshadern, Med Klin 2, D-81377 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Neurol Klin, D-81377 Munich, Germany
来源
MEDIZINISCHE WELT | 1998年 / 49卷 / 03期
关键词
Wilson's disease; pathogenesis; diagnosis; treatment;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Wilson's disease is a hereditary disorder of copper metabolism which mainly affects the liver and the central nervous system, but also other organs. It is caused by an impairment of biliary copper excretion and subsequent accumulation of copper in the organism. Mutations in one single gene on chromosome 13 have been identified as the cause of impaired copper excretion. The product of the "Wiison's disease gene" is a copper transporting membrane protein. Patients develop symptoms of the disease mainly between the ages of 5 and 30 years. They may present with fulminant hepatic failure and hemolysis or with signs or symptoms of chronic hepatopathy or movement disorders. The diagnosis is made by clinical, biochemical and histological examinations. The prognosis is good when the diagnosis is made at time and when adequate long-term medical treatment is administered. Wilson's disease, however, is fatal when untreated. liver transplantation is indicated in patients with fulminant hepatic failure or end stage chronic liver disease.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 50 条
  • [31] Acute haemolytic anemia with liver failure as initial clinical manifestations of Wilson's Disease
    Komina, S.
    Petrusevska, G.
    Spasevska, L.
    Janevska, V.
    Kostovski, A.
    Zdravkovski, P.
    Grujovska, S.
    Jankovska, B.
    VIRCHOWS ARCHIV, 2015, 467 : S225 - S225
  • [32] Dent's disease: clinical features and molecular basis
    Claverie-Martin, Felix
    Ramos-Trujillo, Elena
    Garcia-Nieto, Victor
    PEDIATRIC NEPHROLOGY, 2011, 26 (05) : 693 - 704
  • [33] Dent’s disease: clinical features and molecular basis
    Félix Claverie-Martín
    Elena Ramos-Trujillo
    Víctor García-Nieto
    Pediatric Nephrology, 2011, 26 : 693 - 704
  • [34] Clinical Molecular Diagnosis of Wilson Disease
    Bennett, James
    Hahn, Si Houn
    SEMINARS IN LIVER DISEASE, 2011, 31 (03) : 233 - 238
  • [35] Neuropsychiatric manifestations in a series of patients with Wilson's disease
    Paul, N.
    Bagchi, M.
    Ghosal, M. K.
    Roy, A.
    Biswas, A.
    Das, S. K.
    MOVEMENT DISORDERS, 2012, 27 : S75 - S75
  • [36] Discovery of Wilson's Disease from Neurological Manifestations
    Zeribi, B.
    Dehours, E.
    Lauque, D.
    Charpentier, S.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2016, 6 (06): : 417 - 419
  • [37] Clinical, biochemical and molecular characterization of Wilson's disease in Moroccan patients
    Lafhal, Karima
    Sabir, Es-said
    Hakmaoui, Abdelmalek
    Hammoud, Miloud
    Aimrane, Abdelmohcine
    Najeh, Samira
    Assiri, Imane
    Berrachid, Abdelaati
    Imad, Najwa
    Boujemaa, Chaima Ait
    Aziz, Faissal
    Hanafi, Fatima Zahra El
    Lalaoui, Abdessamad
    Aamri, Hasna
    Boyko, Iryna
    Sanchez-Monteagudo, Ana
    Espinos, Carmen
    Sab, Imane Ait
    Aboussair, Nisrine
    Bourrahouat, Aicha
    Fdil, Naima
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2023, 36
  • [38] Wilson's disease, clinical and molecular genetic analysis in Republic of Moldova
    Ciumas, M.
    Sacara, V. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 300 - 301
  • [39] The Clinical Manifestations, Treatment Efficacy and Adverse Drug Reactions in 62 Iranian Children with Wilson Disease
    Najafi, Mehri
    Alimadadi, Hosein
    Arastoo, Leila
    Motamed, Farzaneh
    Khodadad, Ahmad
    Fallahi, Gholamhosein
    Farahmand, Fatemeh
    Doroudian, Rana
    INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2014, 2 (03): : 25 - 29
  • [40] The treatment of Wilson's disease
    Brewer, GJ
    COPPER TRANSPORT AND ITS DISORDERS: MOLECULAR AND CELLULAR ASPECTS, 1999, 448 : 115 - 126